Exclusive

Publication

Byline

Location

US Patent Issued to LTS LOHMANN THERAPIE-SYSTEME on Oct. 27 for "Oral thin film comprising a PVA-tris buffer layer" (German Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,773,392, issued on Oct. 27, was assigned to LTS LOHMANN THERAPIE-SYSTEME AG (Andernach, Germany). "Oral thin film comprising a PVA-tris buffer ... Read More


US Patent Issued to Compagnie Gervais Danone, Universite Laval on Oct. 27 for "Composition for reducing hepatic triglycerides and/or improving glucose metabolism" (Canadian, French Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,773,393, issued on Oct. 27, was assigned to Compagnie Gervais Danone (Paris) and Universite Laval (Quebec, Canada). "Composition for reducing h... Read More


US Patent Issued to SANTEN PHARMACEUTICAL, SINGAPORE HEALTH SERVICES on Oct. 27 for "Use of valproic acid for reducing post-operative scarring following a glaucoma surgery" (Singaporean Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,773,394, issued on Oct. 27, was assigned to SANTEN PHARMACEUTICAL Co. LTD. (Osaka, Japan) and SINGAPORE HEALTH SERVICES PTE LTD (Singapore). "U... Read More


US Patent Issued to INSTITUTE NATIONAL DE RECHERCHE POUR L'AGRICULTURE L'ALIMENTATION ET L'ENVIRONMENT, INSTITUT NATIONAL DES SCIENCES ET INDUSTRIES DU VIVANT ET DE L'ENVIRONMENT, UNIVERSITE PARIS-SACLAY on Oct. 27 for "O-acetylserine for the use thereof in the prevention and treatment of glucose intolerance and the associated diseases" (French Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,773,395, issued on Oct. 27, was assigned to INSTITUTE NATIONAL DE RECHERCHE POUR L'AGRICULTURE L'ALIMENTATION ET L'ENVIRONMENT (Paris), INSTITUT... Read More


US Patent Issued to Alkermes Pharma Ireland on Oct. 27 for "Prodrugs of fumarates and their use in treating various diseases" (Massachusetts Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,773,396, issued on Oct. 27, was assigned to Alkermes Pharma Ireland Ltd. (Dublin). "Prodrugs of fumarates and their use in treating various dis... Read More


US Patent Issued on Oct. 27 for "Treatment of serotonin reuptake inhibitor withdrawal syndrome" (Israeli Inventor)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,773,397, issued on Oct. 27. "Treatment of serotonin reuptake inhibitor withdrawal syndrome" was invented by Mark Hasleton (Raanana, Israel). A... Read More


US Patent Issued to Xyra on Oct. 27 for "Formulations of crystalline budiodarone Form-1" (California Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,773,398, issued on Oct. 27, was assigned to Xyra LLC (Los Altos, Calif.). "Formulations of crystalline budiodarone Form-1" was invented by Pasc... Read More


US Patent Issued to SEOUL NATIONAL UNIVERSITY HOSPITAL, KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY on Oct. 27 for "Composition for prevention or treatment of cardiovascular and metabolic disease comprising noranhydroicaritin" (South Korean Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,773,399, issued on Oct. 27, was assigned to SEOUL NATIONAL UNIVERSITY HOSPITAL (Seoul, South Korea) and KOREA RESEARCH INSTITUTE OF BIOSCIENCE A... Read More


US Patent Issued to The General Hospital on Oct. 27 for "Macrophages/microglia in neuro-inflammation associated with neurodegenerative diseases" (Massachusetts Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,773,400, issued on Oct. 27, was assigned to The General Hospital Corp. (Boston). "Macrophages/microglia in neuro-inflammation associated with n... Read More


US Patent Issued to Eiger Group International on Oct. 27 for "Use of chloroquine compounds for treatment of inflammatory conditions" (California Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,773,402, issued on Oct. 27, was assigned to Eiger Group International Inc. (Palo Alto, Calif.). "Use of chloroquine compounds for treatment of ... Read More